glp-1 covered by cigna CEO on medicare advantage and access program Cigna drops coverage of GLP-1

Cardiovascular outcome studies showed substantial MACE reductions: 13% with liraglutide and 26% with semaglutide

Phase 2 trials demonstrated A1C reductions of up to 2.02% in participants with type 2 diabetes, bringing average levels from 8.1% down to 6.08%

Universal Drugstore is a licensed Canadian pharmacy service that provides access to the same medications at reduced costs for cash-paying patients

Patients should maintain adequate fluid intake and seek urgent medical review if they are unable to keep fluids down

Among these, clinical trials underscore the need to monitor adverse events and consider patient-specific factors when administering retatrutide

We report that in pre-clinical models with significant retatrutide (RETA, LY3437943)-induced weight loss, pancreatic cancer engraftment was reduced, tumor onset was delayed, and progression was attenuated resulting in a 14-fold reduction in tumor volume compared to only 4-fold reduction in single agonist semaglutide-treated mice